These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35525262)

  • 41. 1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction.
    Janssens GN; van der Hoeven NW; Lemkes JS; Everaars H; van de Ven PM; Marques KMJ; Nap A; van Leeuwen MAH; Appelman Y; Knaapen P; Verouden NJW; Allaart CP; Brinckman SL; Saraber CE; Plomp KJ; Timmer JR; Kedhi E; Hermanides RS; Meuwissen M; Schaap J; van der Weerdt AP; van Rossum AC; Nijveldt R; van Royen N
    JACC Cardiovasc Interv; 2019 Nov; 12(22):2272-2282. PubMed ID: 31488353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.
    Nazir SA; McCann GP; Greenwood JP; Kunadian V; Khan JN; Mahmoud IZ; Blackman DJ; Been M; Abrams KR; Shipley L; Wilcox R; Adgey AA; Gershlick AH
    Eur Heart J; 2016 Jun; 37(24):1910-9. PubMed ID: 27147610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Implications of Global Longitudinal Strain by Feature-Tracking Cardiac Magnetic Resonance in ST-Elevation Myocardial Infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Beck A; Plappert D; Gorzala M; Pamminger M; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009404. PubMed ID: 31679391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.
    McCartney PJ; Eteiba H; Maznyczka AM; McEntegart M; Greenwood JP; Muir DF; Chowdhary S; Gershlick AH; Appleby C; Cotton JM; Wragg A; Curzen N; Oldroyd KG; Lindsay M; Rocchiccioli JP; Shaukat A; Good R; Watkins S; Robertson K; Malkin C; Martin L; Gillespie L; Ford TJ; Petrie MC; Macfarlane PW; Tait RC; Welsh P; Sattar N; Weir RA; Fox KA; Ford I; McConnachie A; Berry C;
    JAMA; 2019 Jan; 321(1):56-68. PubMed ID: 30620371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial.
    Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Namdar H; Salehi R; Rezagholizadeh A; Entezari-Maleki T
    Trials; 2023 Oct; 24(1):645. PubMed ID: 37803449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.
    Sager HB; Husser O; Steffens S; Laugwitz KL; Schunkert H; Kastrati A; Ndrepepa G; Kessler T
    J Transl Med; 2019 May; 17(1):180. PubMed ID: 31142323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis-based definition of left ventricular remodeling after ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Tiller C; Feistritzer HJ; Kofler M; Brix A; Mayr A; Klug G; Metzler B
    Eur Radiol; 2019 May; 29(5):2330-2339. PubMed ID: 30547201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trial.
    Gaspar A; Pereira MÁ; Azevedo P; Lourenço A; Marques J; Leite-Moreira A
    Trials; 2015 Sep; 16():398. PubMed ID: 26350480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
    Pezel T; Besseyre des Horts T; Schaaf M; Croisille P; Bière L; Garcia-Dorado D; Jossan C; Roubille F; Cung TT; Prunier F; Meyer E; Amaz C; Derumeaux G; de Poli F; Hovasse T; Gilard M; Bergerot C; Thibault H; Ovize M; Mewton N
    Arch Cardiovasc Dis; 2020 Nov; 113(11):710-720. PubMed ID: 33160891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.
    Marcos-Garcés V; Perez N; Gavara J; Lopez-Lereu MP; Monmeneu JV; Rios-Navarro C; de Dios E; Merenciano-González H; Gabaldon-Pérez A; Cànoves J; Racugno P; Bonanad C; Minana G; Nunez J; Moratal D; Chorro FJ; Valente F; Lorenzatti D; Ortiz-Pérez JT; Rodríguez-Palomares JF; Bodi V
    Int J Cardiol; 2022 Feb; 349():150-154. PubMed ID: 34826497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Usefulness of Assessing Heart Rate Variability in Patients with Acute Myocardial Infarction (HeaRt-V-AMI).
    Brinza C; Floria M; Covic A; Covic A; Scripcariu DV; Burlacu A
    Sensors (Basel); 2022 May; 22(9):. PubMed ID: 35591260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST-segment elevation myocardial infarction.
    Gu YL; Haeck JD; Vogelzang M; Bilodeau L; Krucoff MW; Tijssen JG; de Winter RJ; Zijlstra F; Koch KT
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):174-81. PubMed ID: 20518003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
    Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.